Tirzepatide antidiabetic drug action, illustration
Illustration of tirzepatide (red, blue and grey spheres) bound to a glucagon-like peptide-1 (GLP-1) transmembrane receptor (multi-coloured 3d structure across membrane). A G-protein, part of the GLP-1 signalling cascade, is visible below the membrane as a rounded, multicoloured structure. Tirzepatide is a drug used to treat type 2 diabetes. It functions by mimicking glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) hormones, which are secreted in the gastrointestinal tract when we eat. They work by binding to GLP-1 and GIP receptors throughout the body and stimulating insulin secretion, inhibiting glucagon secretion, and slowing down gastric emptying. These effects all lower blood sugar levels, making tirzepatide a treatment option for type 2 diabetes.
Size: 3520px × 4977px
Location:
Photo credit: © RAMON ANDRADE 3DCIENCIA/SCIENCE PHOTO LIBRARY / Alamy / Afripics
License: Licensed
Model Released: No
Keywords: -, 2, 3, 3d, 7, action, agonist, analogue, antidiabetic, artwork, background, bilayer, binding, biochemical, biochemistry, biological, biology, blood, bound, cascade, cell, cgi, control, diabetes, digitally, dimensional, drug, endocrine, endocrinological, endocrinology, generated, gip, glp, glp-1, glucagon, glucagon-, glucose-dependent, glycaemic, glycemic, gs, healthcare, helix, hormone, illustration, insulinotropic, loss, ly3298176, mechanism, medical, medication, medicine, membrane, molecular, peptide, peptide-1, peptides, pharma, pharmaceutical, pharmaceuticals, pharmacological, pharmacology, phospholipid, plasma, polypeptide, protein, proteins, receptor, signalling, structure, sugar, system, tirzepatide, transmembrane, treatment, type, weight, yellow
